According to SIGA Technologies's latest financial reports the company's current EPS (TTM) is $0.38. In 2022 the company made an earnings per share (EPS) of $0.46 a decrease over its 2021 EPS that were of $0.92.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.38 | -16.49% |
2022 | $0.46 | -50.66% |
2021 | $0.92 | 28.09% |
2020 | $0.72 | -900% |
2019 | -$0.09000 | -101.71% |
2018 | $5.25 | -1241.3% |
2017 | -$0.46 | -33.33% |
2016 | -$0.69 | -4.17% |
2015 | -$0.72 | -85.48% |
2014 | -$4.96 | 1450% |
2013 | -$0.32 | 18.52% |
2012 | -$0.27 | -147.37% |
2011 | $0.57 | -150.89% |
2010 | -$1.12 | 160.47% |
2009 | -$0.43 | 65.38% |
2008 | -$0.26 | 52.94% |
2007 | -$0.17 | -51.43% |
2006 | -$0.35 | 250% |
2005 | -$0.10 | -75% |
2004 | -$0.40 | 17.65% |
2003 | -$0.34 | 9.68% |
2002 | -$0.31 | -29.55% |
2001 | -$0.44 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | -$7.83 | -2,160.53% | ๐บ๐ธ USA |
Novavax NVAX | -$7.19 | -1,992.11% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | -$2.40 | -731.58% | ๐บ๐ธ USA |
NanoViricides NNVC | -$0.59 | -255.26% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$1.25 | -428.95% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | -$12.08 | -3,278.95% | ๐บ๐ธ USA |